The global Depression-MDD Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Selective Serotonin Reuptake Inhibitors, Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Depression-MDD Drugs include Reviva Pharmaceuticals Holdings, H. Lundbeck, GlaxoSmithKline, Eli Lilly, Janssen Pharmaceuticals, Pfizer, Merck, AstraZeneca and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Depression-MDD Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression-MDD Drugs. This report contains market size and forecasts of Depression-MDD Drugs in global, including the following market information:
Global Depression-MDD Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
We surveyed the Depression-MDD Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Depression-MDD Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Depression-MDD Drugs Market Segment Percentages, by Type, 2022 (%)
Selective Serotonin Reuptake Inhibitors,
Serotonin & Norepinephrine Reuptake Inhibitors
Atypical Antidepressants
Tricyclic Antidepressants
Global Depression-MDD Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Depression-MDD Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Online Pharmacy
Other
Global Depression-MDD Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Depression-MDD Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Depression-MDD Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Depression-MDD Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Reviva Pharmaceuticals Holdings
H. Lundbeck
GlaxoSmithKline
Eli Lilly
Janssen Pharmaceuticals
Pfizer
Merck
AstraZeneca
Bristol-Myers Squibb
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Depression-MDD Drugs, market overview.
Chapter 2: Global Depression-MDD Drugs market size in revenue.
Chapter 3: Detailed analysis of Depression-MDD Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Depression-MDD Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Depression-MDD Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Depression-MDD Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Depression-MDD Drugs Overall Market Size
2.1 Global Depression-MDD Drugs Market Size: 2022 VS 2029
2.2 Global Depression-MDD Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Depression-MDD Drugs Players in Global Market
3.2 Top Global Depression-MDD Drugs Companies Ranked by Revenue
3.3 Global Depression-MDD Drugs Revenue by Companies
3.4 Top 3 and Top 5 Depression-MDD Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Depression-MDD Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Depression-MDD Drugs Players in Global Market
3.6.1 List of Global Tier 1 Depression-MDD Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Depression-MDD Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Depression-MDD Drugs Market Size Markets, 2022 & 2029
4.1.2 Selective Serotonin Reuptake Inhibitors,
4.1.3 Serotonin & Norepinephrine Reuptake Inhibitors
4.1.4 Atypical Antidepressants
4.1.5 Tricyclic Antidepressants
4.2 By Type - Global Depression-MDD Drugs Revenue & Forecasts
4.2.1 By Type - Global Depression-MDD Drugs Revenue, 2018-2023
4.2.2 By Type - Global Depression-MDD Drugs Revenue, 2024-2029
4.2.3 By Type - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Depression-MDD Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Online Pharmacy
5.1.5 Other
5.2 By Application - Global Depression-MDD Drugs Revenue & Forecasts
5.2.1 By Application - Global Depression-MDD Drugs Revenue, 2018-2023
5.2.2 By Application - Global Depression-MDD Drugs Revenue, 2024-2029
5.2.3 By Application - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Depression-MDD Drugs Market Size, 2022 & 2029
6.2 By Region - Global Depression-MDD Drugs Revenue & Forecasts
6.2.1 By Region - Global Depression-MDD Drugs Revenue, 2018-2023
6.2.2 By Region - Global Depression-MDD Drugs Revenue, 2024-2029
6.2.3 By Region - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Depression-MDD Drugs Revenue, 2018-2029
6.3.2 US Depression-MDD Drugs Market Size, 2018-2029
6.3.3 Canada Depression-MDD Drugs Market Size, 2018-2029
6.3.4 Mexico Depression-MDD Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Depression-MDD Drugs Revenue, 2018-2029
6.4.2 Germany Depression-MDD Drugs Market Size, 2018-2029
6.4.3 France Depression-MDD Drugs Market Size, 2018-2029
6.4.4 U.K. Depression-MDD Drugs Market Size, 2018-2029
6.4.5 Italy Depression-MDD Drugs Market Size, 2018-2029
6.4.6 Russia Depression-MDD Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Depression-MDD Drugs Market Size, 2018-2029
6.4.8 Benelux Depression-MDD Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Depression-MDD Drugs Revenue, 2018-2029
6.5.2 China Depression-MDD Drugs Market Size, 2018-2029
6.5.3 Japan Depression-MDD Drugs Market Size, 2018-2029
6.5.4 South Korea Depression-MDD Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Depression-MDD Drugs Market Size, 2018-2029
6.5.6 India Depression-MDD Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Depression-MDD Drugs Revenue, 2018-2029
6.6.2 Brazil Depression-MDD Drugs Market Size, 2018-2029
6.6.3 Argentina Depression-MDD Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Depression-MDD Drugs Revenue, 2018-2029
6.7.2 Turkey Depression-MDD Drugs Market Size, 2018-2029
6.7.3 Israel Depression-MDD Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Depression-MDD Drugs Market Size, 2018-2029
6.7.5 UAE Depression-MDD Drugs Market Size, 2018-2029
7 Depression-MDD Drugs Companies Profiles
7.1 Reviva Pharmaceuticals Holdings
7.1.1 Reviva Pharmaceuticals Holdings Company Summary
7.1.2 Reviva Pharmaceuticals Holdings Business Overview
7.1.3 Reviva Pharmaceuticals Holdings Depression-MDD Drugs Major Product Offerings
7.1.4 Reviva Pharmaceuticals Holdings Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.1.5 Reviva Pharmaceuticals Holdings Key News & Latest Developments
7.2 H. Lundbeck
7.2.1 H. Lundbeck Company Summary
7.2.2 H. Lundbeck Business Overview
7.2.3 H. Lundbeck Depression-MDD Drugs Major Product Offerings
7.2.4 H. Lundbeck Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.2.5 H. Lundbeck Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Depression-MDD Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Depression-MDD Drugs Major Product Offerings
7.4.4 Eli Lilly Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Janssen Pharmaceuticals
7.5.1 Janssen Pharmaceuticals Company Summary
7.5.2 Janssen Pharmaceuticals Business Overview
7.5.3 Janssen Pharmaceuticals Depression-MDD Drugs Major Product Offerings
7.5.4 Janssen Pharmaceuticals Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.5.5 Janssen Pharmaceuticals Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Depression-MDD Drugs Major Product Offerings
7.6.4 Pfizer Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Depression-MDD Drugs Major Product Offerings
7.7.4 Merck Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Depression-MDD Drugs Major Product Offerings
7.8.4 AstraZeneca Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Depression-MDD Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Depression-MDD Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Depression-MDD Drugs Revenue in Global Market (2018-2023)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Depression-MDD Drugs Market Opportunities & Trends in Global Market
Table 2. Depression-MDD Drugs Market Drivers in Global Market
Table 3. Depression-MDD Drugs Market Restraints in Global Market
Table 4. Key Players of Depression-MDD Drugs in Global Market
Table 5. Top Depression-MDD Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Depression-MDD Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Depression-MDD Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Depression-MDD Drugs Product Type
Table 9. List of Global Tier 1 Depression-MDD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Depression-MDD Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Depression-MDD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Depression-MDD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Depression-MDD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Depression-MDD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Depression-MDD Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Depression-MDD Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Depression-MDD Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Depression-MDD Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Depression-MDD Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Depression-MDD Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Depression-MDD Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Depression-MDD Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Depression-MDD Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Depression-MDD Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Depression-MDD Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Depression-MDD Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Depression-MDD Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Depression-MDD Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Depression-MDD Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Reviva Pharmaceuticals Holdings Company Summary
Table 31. Reviva Pharmaceuticals Holdings Depression-MDD Drugs Product Offerings
Table 32. Reviva Pharmaceuticals Holdings Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Reviva Pharmaceuticals Holdings Key News & Latest Developments
Table 34. H. Lundbeck Company Summary
Table 35. H. Lundbeck Depression-MDD Drugs Product Offerings
Table 36. H. Lundbeck Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. H. Lundbeck Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Depression-MDD Drugs Product Offerings
Table 40. GlaxoSmithKline Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Eli Lilly Company Summary
Table 43. Eli Lilly Depression-MDD Drugs Product Offerings
Table 44. Eli Lilly Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly Key News & Latest Developments
Table 46. Janssen Pharmaceuticals Company Summary
Table 47. Janssen Pharmaceuticals Depression-MDD Drugs Product Offerings
Table 48. Janssen Pharmaceuticals Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Janssen Pharmaceuticals Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Depression-MDD Drugs Product Offerings
Table 52. Pfizer Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Depression-MDD Drugs Product Offerings
Table 56. Merck Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Depression-MDD Drugs Product Offerings
Table 60. AstraZeneca Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Depression-MDD Drugs Product Offerings
Table 64. Bristol-Myers Squibb Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Company Summary
Table 67. Teva Pharmaceutical Industries Depression-MDD Drugs Product Offerings
Table 68. Teva Pharmaceutical Industries Depression-MDD Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Teva Pharmaceutical Industries Key News & Latest Developments
List of Figures
Figure 1. Depression-MDD Drugs Segment by Type in 2022
Figure 2. Depression-MDD Drugs Segment by Application in 2022
Figure 3. Global Depression-MDD Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Depression-MDD Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Depression-MDD Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Depression-MDD Drugs Revenue in 2022
Figure 8. By Type - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Depression-MDD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Depression-MDD Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 16. US Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 28. China Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Depression-MDD Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Depression-MDD Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Reviva Pharmaceuticals Holdings Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. H. Lundbeck Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GlaxoSmithKline Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Janssen Pharmaceuticals Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AstraZeneca Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Teva Pharmaceutical Industries Depression-MDD Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
